SPARKLE
SPARKLE is a Beijing-based software company that develops an AI-powered pediatric clinical decision support system co-developed with the National Children's Medical Center (Beijing) and Beijing Children's Hospital, serving children's hospitals and regional medical consortiums across Hebei and Anhui provinces.
- Company typePrivate
- Founded2000
- HeadquartersBeijing, China
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What SPARKLE does
SPARKLE (Beijing Sparkle Technology Development Co Ltd / 北京思普科软件股份有限公司) is a Beijing-based private software company founded in 2000 that develops AI-powered pediatric clinical decision support systems and medical big data platforms for the Chinese healthcare sector. Its core offering is the Pediatric AI Series Products (儿科AI系列产品), an intelligent pediatric auxiliary diagnosis system co-developed with the National Children's Medical Center (Beijing) and Beijing Children's Hospital that claims 95%+ comprehensive diagnostic accuracy across common childhood diseases including respiratory, digestive, allergic, dermatological, and neurological conditions. The system uses AI and large language model technology to deliver real-time disease diagnosis prediction, severity assessment, missed-diagnosis alerts, treatment recommendations, and referral suggestions. Version 4.0, released in 2025, segments the product into three editions (Specialist, Outpatient, and Medical Consortium) and adds integrated clinical consultation, treatment planning, simulation training, and physician training modules built on real-world EMR and imaging data.
SPARKLE firmographics
Firmographics- Name
- SPARKLE
- Legal name
- BEIJING SPARKLE TECHNOLOGY DEVELOPMENT CO LTD
- Website
- https://sparkletech.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- SPARKLE is a Beijing-based software company that develops an AI-powered pediatric clinical decision support system co-developed with the National Children's Medical Center (Beijing) and Beijing Children's Hospital, serving children's hospitals and regional medical consortiums across Hebei and Anhui provinces.
- Ownership category
- akta.pro rank
SPARKLE industry classification
Industry- Product category
- Healthcare Clinical Decision Support Software
- NAICS
- Other Computer Related Services (541519)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Pediatrics & Adolescent Therapeutics (Digital) (HLACANAL)
- akta.pro secondary industry
- Medical Imaging AI (HDAAAEAH)
Keywords
Where SPARKLE is headquartered
LocationHeadquarters
- HQ city
- Beijing
- HQ country
- China
- HQ region
- Asia
Offices1 record
Markets served
SPARKLE business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales
Distribution channels1 record
Marketing channels1 record
SPARKLE product offering
Product offeringCore offering
SPARKLE develops and sells the Pediatric AI Series Products (儿科AI系列产品), an AI- and large language model-based pediatric clinical decision support system co-developed with Beijing Children's Hospital and National Children's Medical Center (Beijing). The system provides real-time disease diagnosis, severity assessment, missed-diagnosis prevention, treatment recommendations, and referral suggestions covering common pediatric conditions with 95%+ comprehensive accuracy, and is available in Specialist, Outpatient, and Medical Consortium editions. Supporting offerings include a medical big data platform aggregating nearly 20 billion records, a no-code disease diagnosis logic building platform, and a BPMN 2.0-based AI diagnosis model development engine.
Product overview
SPARKLE offers a unified product portfolio centered on medical big data and AI-assisted clinical diagnosis, primarily serving the healthcare sector with a focus on pediatrics. The core offering is the 儿科AI系列产品 (Pediatric AI Series Products), an intelligent pediatric assisted diagnosis system developed jointly with Beijing Children's Hospital and National Children's Medical Center. This system is supported by the 疾病诊疗智能搭建平台 for building no-code disease diagnosis workflows and the 人工智能诊疗模型开发引擎 for AI model development using BPMN 2.0 workflows. Underpinning these AI products is the 医疗大数据平台, which aggregates nearly 20 billion medical records into 184 data models. The product line covers 29 pediatric respiratory diseases and is available in three editions (Specialist, Outpatient, and Medical Consortium) across regional healthcare consortiums in Hebei and Anhui provinces.
Differentiator
Problem solved
Functional benefit
Products and services
- Pediatric AI Series Products (儿科AI系列产品) AI-assisted pediatric clinical diagnosis system co-developed with Beijing Children's Hospital and National Children's Medical Center (Beijing). Uses AI and large language model technology to provide real-time disease diagnosis, severity assessment, missing-diagnosis prevention, treatment recommendations, and referral suggestions across common pediatric conditions with 95%+ comprehensive accuracy. Available in Specialist, Outpatient, and Medical Consortium editions for hospitals and medical alliances.
- Disease Diagnosis Intelligent Building Platform (疾病诊疗智能搭建平台) No-code intelligent platform for graphically building disease diagnosis logic workflows. Supports flexible and rapid adjustment of diagnosis logic based on latest treatment guidelines and physician experience. Pre-loaded with 29 pediatric respiratory disease diagnosis logics developed with Beijing Children's Hospital respiratory experts, covering pneumonia, laryngitis, acute bronchitis, chronic cough, mycoplasma pneumonia, bronchial asthma, bronchiolitis, upper respiratory infections, and related conditions.
- AI Diagnosis Model Development Engine (人工智能诊疗模型开发引擎) Proprietary AI diagnosis model development engine based on a BPMN 2.0 workflow engine. Provides a no-code graphical interface for designing and configuring AI diagnosis models and clinical decision support workflows, with detailed node configuration and automatic path execution based on diagnosis logic.
- Medical Big Data Platform (医疗大数据平台) Healthcare and medical insurance data platform aggregating nearly 20 billion medical data records, 184 mature data models, 125 dimension dictionaries, and over 130 million total data entries. Provides flexible data modeling and componentized assembly for healthcare management, insurance, medical consumables, and pharmaceutical industry use cases.
Quantifiable outcome
- 95%+ comprehensive diagnosis accuracy rate reflecting top pediatric expert diagnostic logic
- +4 more outcomes
Companies that use SPARKLE
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles2 records
SPARKLE technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature4 records
SPARKLE partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- 国家儿童医学中心（北京）/ 北京儿童医院 (National Children's Medical Center (Beijing) / Beijing Children's Hospital)flagshipStrategic co-development partnership for pediatric AI diagnosis system. Beijing Sparkle Software Co., Ltd. developed the 'Pediatric Intelligent Medical Expert System' jointly with National Children's Medical Center (Beijing) and Beijing Children's Hospital. The system utilizes historical electronic medical records, pediatric textbooks, evidence-based guidelines, and expert knowledge from Beijing Children's Hospital. The National Children's Medical Center serves as supervisor for the product, and the company's 1.0 version was released in 2018. Both parties jointly applied for six software copyrights.
Scale indicators7 records
Recent moves5 records
Expansion highlights6 records
SPARKLE competitors and assessment
Company assessmentBroad incumbents
- Alibaba Health (阿里健康): Hong Kong-listed Alibaba healthcare arm operating pharma e-commerce, telemedicine, and AI-enabled health platforms — comparable as a broad Chinese digital health incumbent with resources to expand into pediatric clinical AI.
- Ping An Healthcare and Technology: Ping An Group's healthcare and technology arm, combining telemedicine, AI-driven consultation, and insurance data — analogous as a broad incumbent with both clinical AI and insurance-data capabilities overlapping SPARKLE's roadmap.
- Tencent (Miying / 觅影): Chinese tech giant operating Miying, a medical imaging and clinical AI platform, alongside a much broader healthcare portfolio — comparable as a large-scale Chinese medical AI incumbent with overlapping hospital AI ambitions.
- WeDoctor (微医): Major Chinese digital health platform offering online consultation, AI-assisted diagnosis, and regional medical alliance services — closely comparable to SPARKLE's medical consortium model and pediatric AI deployment approach.
- Baidu Health (百度健康): Baidu's healthcare unit combining AI medical consultation, health content, and LLM-driven clinical tools — comparable as a Chinese tech incumbent with resources to deploy general AI clinical assistants competing with SPARKLE's pediatric focus.
Direct peers
- Infervision (推想科技): China-based AI medical imaging and clinical decision support vendor with deep hospital channel penetration and a focus on AI-assisted diagnosis — analogous to SPARKLE in deploying AI clinical support into Chinese hospital networks.
- LinkDoc Technology (零氪科技): Chinese healthcare data AI company focused on oncology real-world evidence and clinical decision support — comparable to SPARKLE in leveraging large medical datasets to power AI-driven hospital workflows in China.
- Yidu Tech: Hong Kong-listed Chinese healthcare big data and AI company building clinical decision support, real-world evidence, and AI models on top of large medical datasets — closely comparable to SPARKLE's medical big data platform + pediatric AI stack targeting Chinese hospitals.
- Synyi AI (森亿智能): Chinese AI vendor specializing in clinical decision support, hospital data analytics, and AI assistants for physicians — directly comparable in deploying AI clinical decision tools into Chinese hospital systems.
Emerging players
- iCarbonX (碳云智能): Chinese health-data AI company building multi-omics and clinical data platforms with AI-driven health insights — adjacent peer leveraging large medical/health datasets for AI-driven clinical and consumer applications.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
SPARKLE social profiles
Digital presenceSPARKLE compliance and trust
Trust signalCompliance2 records
SPARKLE financial estimates
Financial estimateRevenue estimate
Valuation estimate
SPARKLE leadership team
Management profileNumber of profiles
SPARKLE funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SPARKLE M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SPARKLE
What does SPARKLE do?
SPARKLE develops and sells the Pediatric AI Series Products (儿科AI系列产品), an AI- and large language model-based pediatric clinical decision support system co-developed with Beijing Children's Hospital and National Children's Medical Center (Beijing). The system provides real-time disease diagnosis, severity assessment, missed-diagnosis prevention, treatment recommendations, and referral suggestions covering common pediatric conditions with 95%+ comprehensive accuracy, and is available in Specialist, Outpatient, and Medical Consortium editions. Supporting offerings include a medical big data platform aggregating nearly 20 billion records, a no-code disease diagnosis logic building platform, and a BPMN 2.0-based AI diagnosis model development engine.
Is SPARKLE a public or private company?
SPARKLE is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was SPARKLE founded?
SPARKLE was founded in 2000. It employs 11 to 50 people.
Where is SPARKLE based?
SPARKLE is headquartered in Beijing, China, in the Asia region.
Who are SPARKLE's main competitors?
Broad incumbents on record are Alibaba Health (阿里健康), Ping An Healthcare and Technology, Tencent (Miying / 觅影), WeDoctor (微医) and Baidu Health (百度健康). Direct peers are Infervision (推想科技), LinkDoc Technology (零氪科技), Yidu Tech and Synyi AI (森亿智能). iCarbonX (碳云智能) is listed as an emerging player.
Does SPARKLE have an API?
No public API is recorded for SPARKLE.
What industry is SPARKLE in?
SPARKLE's product category is Healthcare Clinical Decision Support Software. Its primary akta.pro industry code is HLACANAL, Pediatrics & Adolescent Therapeutics (Digital), with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 541519 and its SIC code is 8000.